Quipt Home Medical (QIPT) to Release Earnings on Monday

Quipt Home Medical (NASDAQ:QIPT) is expected to post its Q3 2025 quarterly earnings results after the market closes on Monday, August 11th. Analysts expect Quipt Home Medical to post earnings of $0.03 per share and revenue of $80.37 million for the quarter.

Quipt Home Medical (NASDAQ:QIPT) last posted its quarterly earnings results on Monday, May 12th. The company reported ($0.07) EPS for the quarter, missing the consensus estimate of $0.02 by ($0.09). Quipt Home Medical had a negative return on equity of 8.38% and a negative net margin of 3.66%. The company had revenue of $57.40 million during the quarter, compared to analysts’ expectations of $88.29 million. On average, analysts expect Quipt Home Medical to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Quipt Home Medical Trading Down 0.5%

Shares of QIPT opened at $2.13 on Friday. Quipt Home Medical has a 1-year low of $1.35 and a 1-year high of $3.37. The company has a 50-day moving average of $2.00 and a 200 day moving average of $2.23. The firm has a market capitalization of $92.53 million, a price-to-earnings ratio of -10.14 and a beta of 0.59. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.22 and a quick ratio of 0.85.

Institutional Trading of Quipt Home Medical

An institutional investor recently bought a new position in Quipt Home Medical stock. Jane Street Group LLC acquired a new position in Quipt Home Medical Corp. (NASDAQ:QIPT) in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 53,105 shares of the company’s stock, valued at approximately $124,000. Jane Street Group LLC owned 0.12% of Quipt Home Medical at the end of the most recent reporting period. 42.85% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

QIPT has been the subject of a number of research analyst reports. Wall Street Zen lowered shares of Quipt Home Medical from a “hold” rating to a “sell” rating in a report on Thursday, May 22nd. Canaccord Genuity Group reiterated a “hold” rating and set a $1.70 price objective (down previously from $4.00) on shares of Quipt Home Medical in a report on Tuesday, May 13th. Finally, Benchmark reiterated a “buy” rating and set a $4.00 price objective (down previously from $6.00) on shares of Quipt Home Medical in a report on Wednesday, May 14th.

Quipt Home Medical Company Profile

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.